
This meta-analysis examined the association between glycated albumin (GA) levels and the risk of cardiovascular disease (CVD) and mortality in patients with and without dialysis. It includes data from 17 cohort studies involving 80,024 participants. The results indicate that higher levels of GA are associated with an increased risk of CV mortality, all-cause mortality, major adverse cardio-cerebral events, coronary artery disease, and stroke. The study concludes that high GA levels are linked to an increased risk of CVD and mortality, regardless of dialysis status.
Like
Save
Share